Carmat S.A. (CKMTF)
Stock analysis · OTC · Healthcare · Medical - Devices
$12.75
Market Cap
$85.19M
PE (TTM)
-5.22
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
1.38
Day Range
$12.75 – $12.75
52-wk Range
$12.75 – $12.75
Avg Volume
N/A
Volume
448.00
Carmat S.A. (CKMTF) is a publicly traded company in the Healthcare sector. Latest price: $12.75. Market cap $85.19M. Trailing PE -5.22. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Most Recent
Apr 23, 2024
EPS $-1.17 vs est. $-1.17
Beat by $0.00
Proprietary Signals
About Carmat S.A.
Carmat S.A. is dedicated to engineering and producing cutting-edge total artificial hearts. These innovative devices are developed to aid patients afflicted with severe, end-stage biventricular heart failure, serving markets in France and across the globe. The company was established in 2008 and operates from its primary base in Vélizy-Villacoublay, France.
Valuation
| P/E (TTM) | -5.22× |
|---|---|
| P/S (TTM) | 27.15× |
| P/B | -6.44× |
| P/FCF (TTM) | -1.30× |
| EV / EBITDA | -2.49× |
| EV / Sales | 44.88× |
| Earnings Yield | -19.11% |
| Free Cash Flow Yield | -76.95% |
Fundamentals
| Enterprise Value | $125.66M |
|---|---|
| Revenue (TTM) | $2.80M |
| Net Income (TTM) | -$14.53M |
| Free Cash Flow (TTM) | -$55.19M |
| Net Debt | $49.64M |
| Working Capital | $21.95M |
| Gross Margin | -1726.61% |
| Operating Margin | -1875.00% |
| Net Margin | -1925.00% |
| Return on Equity | 257.94% |
| Return on Invested Capital | -98.44% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap